Nina Kim

1.3k total citations
58 papers, 961 citations indexed

About

Nina Kim is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Nina Kim has authored 58 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Immunology and 10 papers in Oncology. Recurrent topics in Nina Kim's work include Multiple Myeloma Research and Treatments (12 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Nina Kim is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Nina Kim collaborates with scholars based in United States, India and Switzerland. Nina Kim's co-authors include Richard P. Phipps, Patricia J. Sime, Jennifer Galbraith, Amanda Croasdell, Xiaoming Li, Kay Dickersin, Parker F. Duffney, Bonita Stanton, Shannon H. Lacy and Sesquile Ramon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nina Kim

52 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Kim United States 15 210 210 189 157 126 58 961
Edward Ruiz-Narváez United States 26 347 1.7× 151 0.7× 63 0.3× 51 0.3× 174 1.4× 91 1.7k
Milton César Foss Brazil 22 364 1.7× 138 0.7× 140 0.7× 37 0.2× 162 1.3× 95 1.8k
J. Preiß Germany 21 257 1.2× 402 1.9× 49 0.3× 140 0.9× 422 3.3× 80 1.7k
Moon Young Kim South Korea 25 299 1.4× 208 1.0× 54 0.3× 75 0.5× 208 1.7× 149 1.9k
Norbert Gilmore Canada 20 189 0.9× 253 1.2× 134 0.7× 645 4.1× 350 2.8× 65 1.9k
Norma C. Serrano Colombia 21 141 0.7× 212 1.0× 151 0.8× 47 0.3× 249 2.0× 72 1.4k
Ian Craft United Kingdom 34 448 2.1× 241 1.1× 121 0.6× 36 0.2× 126 1.0× 191 3.5k
Benjamı́n Trujillo-Hernández Mexico 20 91 0.4× 88 0.4× 82 0.4× 108 0.7× 166 1.3× 101 1.1k
Clement L. Ren United States 29 258 1.2× 268 1.3× 62 0.3× 130 0.8× 295 2.3× 112 3.0k
Mark W. Babyatsky United States 19 457 2.2× 323 1.5× 138 0.7× 57 0.4× 112 0.9× 36 1.4k

Countries citing papers authored by Nina Kim

Since Specialization
Citations

This map shows the geographic impact of Nina Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Kim more than expected).

Fields of papers citing papers by Nina Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Kim. The network helps show where Nina Kim may publish in the future.

Co-authorship network of co-authors of Nina Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Kim. A scholar is included among the top collaborators of Nina Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Kim. Nina Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jauregui, Ruben, et al.. (2025). Chronic Neuropsychiatric Sequelae Associated With Kambo Intoxication. JAMA Neurology. 82(4). 418–418.
2.
Dhakal, Binod, Nina Kim, William S. John, et al.. (2024). Real-World Patient Characteristics and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US. Blood. 144(Supplement 1). 7843–7843. 1 indexed citations
3.
Huntington, Scott F., Dee Lin, Marie‐Hélène Lafeuille, et al.. (2024). Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy. Pharmacology Research & Perspectives. 12(6). e70024–e70024.
4.
Chen, Yang, Maureen Canavan, Nina Kim, et al.. (2024). Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma. Journal of Palliative Medicine. 27(7). 879–887. 1 indexed citations
5.
6.
7.
8.
Lin, Dee, Bingcao Wu, Nina Kim, et al.. (2024). Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group. SHILAP Revista de lepidopterología. 4. 1354760–1354760. 2 indexed citations
9.
Kim, Nina, et al.. (2023). The Relative Value of Anti-Obesity Medications Compared to Similar Therapies. ClinicoEconomics and Outcomes Research. Volume 15. 51–62. 7 indexed citations
10.
11.
Garvey, W. Timothy, Abhilasha Ramasamy, B. Gabriel Smolarz, et al.. (2023). Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program. Population Health Management. 26(1). 72–82. 3 indexed citations
12.
Sekeres, Mikkael A., Nina Kim, Amy E. DeZern, et al.. (2023). Considerations for Drug Development in Myelodysplastic Syndromes. Clinical Cancer Research. 29(14). 2573–2579. 3 indexed citations
13.
Mease, Philip J., Taylor Blachley, Blessing Dube, et al.. (2022). Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of Rheumatology. 49(7). 700–706. 4 indexed citations
14.
Hur, Peter, Esther Yi, Raluca Ionescu‐Ittu, et al.. (2021). Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings. Rheumatology and Therapy. 9(1). 265–283. 3 indexed citations
15.
Hur, Peter, Kathleen G. Lomax, Raluca Ionescu‐Ittu, et al.. (2021). Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States. Pediatric Rheumatology. 19(1). 143–143. 1 indexed citations
16.
Ogdie, Alexis, et al.. (2021). Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis. Arthritis Research & Therapy. 23(1). 252–252. 14 indexed citations
17.
Kim, Nina, et al.. (2021). Anticholinergic Cognitive Burden in Older People Over Acute Admission. The Senior Care Pharmacist. 36(2). 104–111. 3 indexed citations
18.
Çoruh, Başak, et al.. (2018). Immune reconstitution inflammatory syndrome associated with disseminated histoplasmosis and TNF-alpha inhibition. Medical Mycology Case Reports. 23. 62–64. 10 indexed citations
19.
Kim, Nina, Thomas H. Thatcher, Patricia J. Sime, & Richard P. Phipps. (2017). Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients. JCI Insight. 2(3). e88588–e88588. 16 indexed citations
20.
Kim, Nina, Bonita Stanton, Xiaoming Li, Kay Dickersin, & Jennifer Galbraith. (1997). Effectiveness of the 40 adolescent AIDS-risk reduction interventions: A quantitative review. Journal of Adolescent Health. 20(3). 204–215. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Ruiz-Narváez Breakdown of academic impact, for papers by Milton César Foss Breakdown of academic impact, for papers by J. Preiß Breakdown of academic impact, for papers by Moon Young Kim Breakdown of academic impact, for papers by Norbert Gilmore Breakdown of academic impact, for papers by Norma C. Serrano Breakdown of academic impact, for papers by Ian Craft Breakdown of academic impact, for papers by Benjamı́n Trujillo-Hernández Breakdown of academic impact, for papers by Clement L. Ren Breakdown of academic impact, for papers by Mark W. Babyatsky
Rankless by CCL
2026